Previous 10 | Next 10 |
Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The strategy seeks to invest in a small number of industry-leading companies with sustainable competitive advantages and the opportunity to generate durab...
I will outline the history of drug development. Information for the Abcam business model will be outlined for my readers. As a secondary model for my readers, I will cite Syneos Health, Inc. For further details see: Abcam: A Promising Business Model In The Drug Industry ...
Pionyr Immunotherapeutics extended its collaboration with Abcam ([[ABCM]] -0.4%) by signing a licensing deal to support the clinical development of its PY314 program to treat solid tumors.PY314 — an anti-TREM2 ((Triggering Receptor Expressed on Myeloid cells 2)) monoclonal antibod...
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients The partnership will support the progression of PY314, the first of Pionyr's Myeloid Tuning™ antibodies to enter the clinic Pionyr will use Abcam's EPR20243 clone to evaluate TRE...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...
Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. Performa...
Building on existing three-year collaboration Focusing on co-development of companion and in vitro diagnostic kits to support demand in China CAMBRIDGE, United Kingdom and SHANGHAI, China, April 12, 2021 (GLOBE NEWSWIRE) -- Abcam (AIM: ABC; NASDAQ: AB...
Avacta Group plc (AVCTF) has entered into a global distribution agreement with ABCAM (ABCM) to sell recently developed SARS-CoV-2 research ELISA Affimer reagents. Avacta has developed Affimer reagents which can be used in a high performance ELISA laboratory test to detect the SARS-CoV-2 ...
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) -- Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced that Dr Alejandra Solache, SVP of Research & Development received the CiteAb award for ‘ Significant Individual...
Abcam plc (ABCZF) 2021 Interim Earnings Conference Call March 8, 2021 9:00 am ET Company Participants Alan Hirzel - Chief Executive Officer Michael Baldock - Chief Financial Officer James Stavely - Vice President, Investor Relations Conference Call Participants Tejas Sevant - Morgan Stanley C...
News, Short Squeeze, Breakout and More Instantly...
Danaher Completes Acquisition of Abcam PR Newswire WASHINGTON , Dec. 6, 2023 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam"). The acquisition of Abcam for $24.0...
Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, entered into a definitive agreement on August 26, 2023 relating to its proposed acquisition by Danaher Corporation (NYSE: DHR) ...
2023-11-19 06:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...